Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya
NCT01468753 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2015-05-15
Summary
To evaluate the acceptability, feasibility, and efficacy of vaginal insemination as a method of conception in HIV discordant couples (female positive, male negative) desiring pregnancy in Kisumu, Kenya
Conditions
- HIV Discordant Couples
Interventions
- PROCEDURE
-
Vaginal Insemination
Women will perform vaginal insemination during the fertile period with semen within one hour of collection. Vaginal insemination will occur within one hour of collection 2 days prior to ovulation, on the day of ovulation and 2 days after ovulation for up to 6 months or until conception occurs. For example, if ovulation were on day 14 of a 28 day menstrual cycle, vaginal insemination will occur on days 12, 14 and 16 of the cycle.
Sponsors & Collaborators
-
Kenya Medical Research Institute
collaborator OTHER -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Betty Njoroge, MB. ChB, MPH · Kenya Medical Research Institute
-
Craig Cohen, MD, MPH · University of California, San Francisco
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 34 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2014-02-28
- Completion
- 2014-02-28
Countries
- Kenya
Study Locations
More Related Trials
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Pregnancy in Women With HIV Infection
NCT04350554 ·Status: UNKNOWN
-
Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
NCT01621347 ·Status: COMPLETED
-
Assessing the Feasibility, Acceptability and Effects Of HIV Birth Testing In Maternity Settings In Zimbabwe
NCT04206241 ·Status: COMPLETED
-
HIV With Innovative Group Antenatal Care in Two African Countries
NCT02999334 ·Status: COMPLETED ·Phase: NA
-
A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies
NCT00000910 ·Status: COMPLETED
-
Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe
NCT03388398 ·Status: COMPLETED
-
Testing Implementation Strategies to Improve Delivery of PrEP for Pregnant and Postpartum Women in Kenya
NCT05482360 ·Status: COMPLETED ·Phase: NA
-
Hormonal Birth Control and the Risk of Acquiring HIV
NCT00006324 ·Status: COMPLETED ·Phase: NA
-
Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi
NCT06397690 ·Status: COMPLETED ·Phase: NA
-
An Integrated Strategy to Support Antiretroviral Therapy and Pre-exposure Prophylaxis Adherence for HIV Prevention in Pregnant and Breastfeeding Women
NCT04330989 ·Status: COMPLETED ·Phase: NA
-
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids
NCT03284645 ·Status: COMPLETED
-
Piloting At-birth Point of Care HIV Testing Strategies in Kenya
NCT03435887 ·Status: COMPLETED ·Phase: NA
-
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
NCT00100867 ·Status: COMPLETED
-
Evaluation of the HITSystem to Improve Early Infant Diagnosis Outcomes in Kenya
NCT02072603 ·Status: COMPLETED ·Phase: NA
-
Family Planning and HIV in Postpartum Women in Mbarara
NCT02964169 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Antiretroviral Agents in HIV-1 Infected Pregnant Women
NCT00006320 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
NCT00197366 ·Status: TERMINATED
-
HIV Exposure in Utero and Metabolic Disease Risk in HIV-Negative Young Adults
NCT04132830 ·Status: COMPLETED
-
Impact of Point-of-Care EID for HIV-Exposed Infants
NCT03824067 ·Status: COMPLETED ·Phase: NA
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
NCT00992017 ·Status: COMPLETED ·Phase: PHASE2
-
Enhanced Virologic Monitoring for Pregnant and Postpartum Women With HIV
NCT05845619 ·Status: COMPLETED ·Phase: NA
-
HIV Testing Strategies in the Perinatal Setting
NCT00503308 ·Status: COMPLETED ·Phase: NA
-
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
NCT00442962 ·Status: COMPLETED ·Phase: PHASE4